C4 Therapeutics, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $78.6M | $61.3M | $74.6M | $58.8M | $78.2M | $51.3M | $55.5M | $59.6M |
| Accounts Receivable | $1.3M | $2.9M | $2.4M | $6.5M | $2.2M | $8.0M | $3.1M | $10.3M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $262.9M | $245.4M | $258.1M | $206.9M | $224.7M | $232.5M | $257.8M | $273.2M |
| Property, Plant & Equipment | $4.1M | $4.5M | $4.7M | $5.1M | $5.5M | $5.5M | $5.8M | $6.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $359.4M | $328.9M | $359.1M | $265.5M | $296.5M | $319.5M | $349.6M | $376.1M |
| Liabilities | ||||||||
| Accounts Payable | $1.1M | $773.0K | $858.0K | $1.3M | $2.2M | $683.0K | $1.3M | $1.5M |
| Total Current Liabilities | $48.2M | $27.2M | $33.0M | $35.9M | $44.5M | $40.8M | $45.2M | $43.3M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $112.1M | $94.6M | $102.5M | $111.1M | $122.5M | $124.4M | $133.6M | $133.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-787.5M | $-763.8M | $-738.7M | $-718.2M | $-686.0M | $-660.0M | $-633.7M | $-599.1M |
| Total Stockholders' Equity | $247.3M | $234.2M | $256.6M | $154.4M | $174.1M | $195.1M | $216.0M | $242.7M |